Validação do protocolo 4-C mortality score na estratificação de risco da covid-19 em pacientes internados em um hospital do Distrito Federal
DOI:
https://doi.org/10.11606/issn.1679-9836.v104i1e-229565Palavras-chave:
4-c Mortality Score, COVID-19, Regras de Decisão ClínicaResumo
A pandemia de COVID-19 impõs desafios aos sistemas de saúde globalmente, incluindo sobrecarga nos serviços de saúde. O objetivo deste estudo foi avaliar a acurácia do 4-C Mortality Score para prever o risco de mortalidade em pacientes com COVID-19 em um hospital público do Distrito Federal. Foi conduzido um estudo retrospectivo com 177 pacientes, utilizando o escore para prever desfechos clínicos, como alta hospitalar ou morte. A taxa de mortalidade observada foi de 15,25%, com 12,99% das mortes ocorrendo nos grupos de risco alto e muito alto segundo o escore. A área sob a curva (AUC) para os grupos de risco foi de 0,748 (0,641 - 0,855), resultando em um desempenho similar ao observado em estudos internacionais. Os resultados indicam que o 4-C Mortality Score pode ser útil para a estimativa de prognóstico em pacientes com COVID-19, auxiliando na tomada de decisões clínicas. No entanto, são necessários mais estudos em diferentes regiões do Brasil para validar esses achados, e a imunização dos pacientes contra COVID-19 não foi considerada nesta análise.
Downloads
Referências
World Health Organization. WHO COVID-19 Dashboard, Geneva, 2021. https://covid19.who.int
Noronha KV, Guedes GR, Turra CM, et al. Pandemia por COVID-19 no Brasil: análise da demanda e da oferta de leitos hospitalares e equipamentos de ventilação assistida segundo diferentes cenários. Cad Saude Publica. 2020;36(6):e00115320. Doi: 10.1590/0102-311X00115320. https://www.scielo.br/j/csp/a/XMbMhFTGYx5v7LtrTC58TcW/. Acesso em: 2 mar. 2021.
Da Silva MH, Procópio IM. A fragilidade do sistema de saúde brasileiro e a vulnerabilidade social diante da COVID-19. Rev Bras Promoc Saude. 2020;33:e10724. Doi: 10.5020/18061230.2020.10724. https://periodicos.unifor.br/RBPS/article/view/10724.
Xavier AR, Silva JS, Almeida JP, et al. COVID-19: manifestações clínicas e laboratoriais na infecção pelo novo coronavírus. J Bras Patol Med Lab. 2020;56:e3232020. Doi: 10.5935/1676-2444.20200049. http://www.gnresearch.org/doi/10.5935/1676-2444.20200049.
Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. Doi: 10.1186/s40779-020-00240-0. https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-020-00240-0.
World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. Interim Guidance, 13 Mar 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.
Centers for Disease Control and Prevention. Assessing Risk Factors for Severe COVID-19 Illness. COVID-19, 30 Nov 2020. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/assessing-risk-factors.html.
Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisal. BMJ. 2020;369:m1328. Doi: 10.1136/bmj.m1328. https://www.bmj.com/content/369/bmj.m1328.
Gupta RK, Harrison EM, Ho A, Docherty AB, Knight SR, van Smeden M, et al. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: An observational cohort study. Eur Respir J. 2020 Sep 25; Doi: 10.1183/13993003.03498-2020. https://erj.ersjournals.com/content/early/2020/09/17/13993003.03498-2020.
Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339. Doi: 10.1136/bmj.m3339. https://www.bmj.com/content/370/bmj.m3339.
Ministério da Saúde. COVID-19: Painel Coronavírus. Brasil, 2021. https://covid.saude.gov.br.
Organização Pan-Americana da Saúde. Histórico da pandemia de COVID-19. 11 mar. 2020. https://www.paho.org/pt/covid19/historico-da-pandemia-covid-19.
Wynants L, Sotgiu G. Improving clinical management of COVID-19: the role of prediction models. Lancet Respir Med. 2021;9(11):1219-21. Doi: 10.1016/S2213-2600(21)00006-0. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00006-0/fulltext.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. Doi: 10.1016/S0140-6736(20)30566-3.
Smits SL, de Lang A, van den Brand JM, Leijten LM, van IJcken WF, Eijkemans MJC, et al. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog. 2010;6(2):e1000756. Doi:10.1371/journal.ppat.1000756. https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1000756.
Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. BMJ. 2020;369:m1966. Doi:10.1136/bmj.m1966. https://www.bmj.com/content/369/bmj.m1966.
Földi M, Farkas N, Kiss S, Zádori N, Váncsa S, Szakó L, et al. Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis. Obes Rev. 2020;21(10):e13095. Doi: 10.1111/obr.13095.
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. Doi:10.1183/13993003.00547-2020.
Knight SR, Gupta RK, Ho A, Pius R, Buchan I, Carson G, et al. Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. Thorax. 2022;77(6):606-15. Doi:10.1136/thoraxjnl-2021-217629.
Wellbelove Z, Walsh C, Perinpanathan T, Lillie P, Barlow G. Comparing the 4C mortality score for COVID-19 to established scores (CURB65, CRB65, qSOFA, NEWS) for respiratory infection patients. J Infect. 2021;82(3):414-51. Doi: 10.1016/j.jinf.2020.10.015.
Fiocruz. Boletim extraordinário 30 de março de 2021. Observatório COVID-19. https://portal.fiocruz.br/observatorio-covid-19.
Lazar Neto F, Marino LO, Torres A, Cilloniz C, Meirelles Marchini JF, Garcia de Alencar JC, et al. Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study. Clin Microbiol Infect. 2021;27(7):1037.e1-1037.e8. Doi: 10.1016/j.cmi.2021.03.002.
van Dam PMEL, Zelis N, van Kuijk SMJ, Linkens AEMJH, Brüggemann RAG, Spaetgens B, van der Horst ICC, Stassen PM. Performance of prediction models for short-term outcome in COVID-19 patients in the emergency department: a retrospective study. Ann Med. 2021;53(1):402-9. Doi: 10.1080/07853890.2021.1891453.
Doğanay F, Ak R. Performance of the CURB-65, ISARIC-4C and COVID-GRAM scores in terms of severity for COVID-19 patients. Int J Clin Pract. 2021;75(10):e14759. Doi: 10.1111/ijcp.14759. https://onlinelibrary.wiley.com/doi/full/10.1111/ijcp.14759.
Ong SWX, Sutjipto S, Lee PH, Dugan C, Khoo BY, Ren D, et al. Validation of ISARIC 4C Mortality and Deterioration Scores in a Mixed Vaccination Status Cohort of Hospitalized Coronavirus Disease 2019 (COVID-19) Patients in Singapore. Clin Infect Dis. 2022;75(1):e874-e877. Doi: 10.1093/cid/ciac087.
Kuroda S, Matsumoto S, Sano T, Kitai T, Yonetsu T, Kohsaka S, et al. External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors. BMJ Open. 2021;11(9):e052708. Doi: 10.1136/bmjopen-2021-052708.
Ocho K, Hagiya H, Hasegawa K, Fujita K, Otsuka F. Clinical Utility of 4C Mortality Scores among Japanese COVID-19 Patients: A Multicenter Study. J Clin Med. 2022;11(3):821. Doi: 10.3390/jcm11030821.
Morello F, Bima P, Giamello JD, Baricocchi D, Risi F, Vesan M, et al. Study Investigators. A 4C mortality score based dichotomic rule supports Emergency Department discharge of COVID-19 patients. Minerva Med. 2022;113(6):916-26. Doi: 10.23736/S0026-4806.21.07779-X.
Jones A, Pitre T, Junek M, Kapralik J, Patel R, Feng E, et al. Investigators. External validation of the 4C mortality score among COVID-19 patients admitted to hospital in Ontario, Canada: a retrospective study. Sci Rep. 2021;11(1):18638. Doi: 10.1038/s41598-021-97332-1.
Gordon AJ, Govindarajan P, Bennett CL, Matheson L, Kohn MA, Camargo C, et al. External validation of the 4C Mortality Score for hospitalised patients with COVID-19 in the RECOVER network. BMJ Open. 2022;12(4):e054700. Doi: 10.1136/bmjopen-2021-054700.
Riley JM, Moeller PJ, Crawford AG, Schaefer JW, Cheney-Peters DR, Venkataraman CM, Li CJ, et al. External validation of the COVID-19 4C mortality score in an urban United States cohort. Am J Med Sci. 2022;364(4):409-13. Doi: 10.1016/j.amjms.2022.04.030.
Aletreby WT, Mumtaz SA, Shahzad SA, Ahmed I, Alodat MA, Gharba M, et al. External Validation of 4C ISARIC Mortality Score in Critically ill COVID-19 Patients from Saudi Arabia. Saudi J Med Med Sci. 2022;10(1):19-24. Doi: 10.4103/sjmms.sjmms_480_21.
Wirth A, Goetschi A, Held U, Sendoel A, Stuessi-Helbling M, Huber LC. External Validation of the Modified 4C Deterioration Model and 4C Mortality Score for COVID-19 Patients in a Swiss Tertiary Hospital. Diagnostics (Basel). 2022;12(5):1129. Doi: 10.3390/diagnostics12051129.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. Doi:10.1016/0021-9681(87)90171-8. https://pubmed.ncbi.nlm.nih.gov/3558716/.
Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health. www.OpenEpi.com.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2025 Victória Piantino, Leonardo Joaquim Soares de Lima, Tarquino Erastides Gavilanes Sanchez
Este trabalho está licenciado sob uma licença Creative Commons Attribution-ShareAlike 4.0 International License.
